Fry E T, Hermiller J B, Peters T F, Orr C M, VanTassel J, Waller B F, Pinkerton C A
Nasser, Smith & Pinkerton Cardiology, Inc., Indiana Heart Institute, St. Vincent Hospital, Indianapolis.
Cardiol Clin. 1994 Nov;12(4):631-49.
The Gianturco-Roubin coronary stent is approved for and effective in the management of acute or threatened closure after unsuccessful coronary intervention. Factors critical to successful stenting include patient and lesion selection, preprocedure identification of patients in potential need of stenting, selection of stent-compatible ancillary equipment, appropriate antiplatelet and anticoagulant therapy, postdeployment stent dilatation, and careful sizing of stents. Further refinements of technique and adjunctive drug therapy should continue to improve results and avoid acute complications. Published clinical experience and potential future applications are discussed.
